'This intermediate-size expanded access protocol plans to treat approximately 50 children or adolescents, male and female, with MIS-C associated with COVID-19. Participants who are 2 months to 17 years of age, inclusive, will be enrolled at multiple clinical sites across the United States."
Still on trial. So it is not price sensitive.
'This intermediate-size expanded access protocol plans to treat...
-
- There are more pages in this discussion • 369 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.015(1.55%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 96.5¢ | 94.5¢ | $1.251M | 1.308M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 323244 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.5¢ | 82874 | 54 |
View Market Depth
| Last trade - 14.08pm 27/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |